stockrowVeracyte, Inc. (VCYT) vs GeneDx Holdings Corp. (WGS)
- Veracyte, Inc. VCYT 24.11 −54.09%
- GeneDx Holdings Corp. WGS 64.89 −6.42%
Veracyte, Inc. and GeneDx Holdings Corp. are both Diagnostics & Research companies. Veracyte, Inc. and GeneDx Holdings Corp. are of similar size ($1.9B and $1.9B). GeneDx Holdings Corp. has negative trailing earnings, so its P/E is not meaningful; Veracyte, Inc. trades at 15.2×. GeneDx Holdings Corp. grew revenue faster over the last twelve months: 25.4% against 17.5%. Veracyte, Inc. has the higher net margin (21.8% vs −23.4%) and the higher return on invested capital (4.33% vs −27.7%). Across the 18 metrics below, Veracyte, Inc. leads on 16 and GeneDx Holdings Corp. on 2.
Valuation
Profitability
| Metric | VCYT | WGS | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 71.98% | 69.37% | 48.32% |
| Operating margin | 17.08% | (20.34%) | (5.68%) |
| Net margin | 21.80% | (23.40%) | (4.10%) |
| Free cash flow margin | 27.84% | (16.68%) | 0.00% |
| Return on equity | 9.43% | (40.80%) | 0.00% |
| Return on assets | 8.63% | (22.50%) | (6.05%) |
| Return on invested capital | 4.33% | (27.70%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack